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Abstract
Background: TEM β-lactamases are the main cause for resistance against β-lactam antibiotics.
Sequence information about TEM β-lactamases is mainly found in the NCBI peptide database and
TEM mutation table at http://www.lahey.org/Studies/temtable.asp. While the TEM mutation table
is manually curated by experts in the lactamase field, who guarantee reliable and consistent
information, the rapidly growing sequence and annotation information from the NCBI peptide
database is sometimes inconsistent. Therefore, the Lactamase Engineering Database has been
developed to collect the TEM β-lactamase sequences from the NCBI peptide database and the TEM
mutation table, systematically compare sequence information and naming, identify inconsistencies,
and thus provide a versatile tool for reconciliation of data and for an investigation of the sequence-
function relationship.
Description: The LacED currently provides 2399 sequence entries and 37 structure entries.
Sequence information on 150 different TEM β-lactamases was derived from the TEM mutation table
which provides a unique number to each protein classified as TEM β-lactamase. 293 TEM-like
proteins were found in the NCBI protein database, but only 113 TEM β-lactamase were common
to both data sets. The 180 TEM β-lactamases from the NCBI protein database which have not yet
been assigned to a TEM number fall in three classes: (1) 89 proteins from microbial organisms and
35 proteins from cloning or expression vectors had a new mutation profile; (2) 55 proteins had
inconsistent annotation in terms of TEM assignment or reported mutation profile; (3) 39 proteins
are fragments. The LacED is web accessible at http://www.LacED.uni-stuttgart.de and contains
multisequence alignments, structure information and reconciled annotation of TEM β-lactamases.
The LacED is weekly updated and supplies all data for download.
Conclusion:  The Lactamase Engineering Database enables a systematic analysis of TEM β-
lactamase sequence and annotation data from different data sources, and thus provides a valuable
tool to identify inconsistencies in sequences from the NCBI peptide database, to detect TEM β-
lactamases with a novel mutation profile, and to identify new amino acid positions at which
mutations can occur.
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Background
β-lactamases (EC 3.5.2.6) are the main cause for resist-
ance against β-lactam antibiotics [1,2], because they inac-
tivate the antibiotics by hydrolysis of the β-lactam ring of
penicillins and cephalosporins. A classification scheme
which was initially proposed by Ambler [3] divides β-
lactamases into four classes (A, B, C, D) based on their
amino acid sequences. In this scheme, β-lactamases of
classes A, C, and D are serine β-lactamases, whereas class
B enzymes are metallo-β-lactamases. Class A β-lactamases
include, among others, the plasmid-borne TEM, SHV, and
CTX-M β-lactamases, which are most commonly found in
gram negative bacteria. Enzymes in this class are charac-
terized by an active-site serine, a molecular mass of
approximately 29 KDa, and the preferential hydrolysis of
penicillin. At the sequence level, the TEM and SHV β-lacta-
mase families share an identity of 67%, while the CTX-M
family is more distant (sequence identity of 40% to TEM
and SHV) [4].
The TEM β-lactamases are derivatives of TEM-1 and TEM-
2 [5]. The premature protein consists of 286 amino acids.
The first 23 amino acids at the N-terminus form the signal
sequence and are removed to yield the active enzyme [6].
TEM-1 was first reported in 1965 in Greece from an
Escherichia coli isolate [6,7]. Within a few years after the
first isolation, the plasmid-mediated TEM-1 β-lactamase
was identified everywhere in the world and in many dif-
ferent bacteria such as Pseudomonas aeruginosa,  Haemo-
philus influenzae, Neisseria meningitidis, Salmonella enterica,
or Shigella flexneri [5]. The β-lactamase producing bacteria
are increasing in number and cause more severe infections
because of continuous mutation of their lactamase genes,
many of them belonging to the TEM β-lactamase family
[4,8]. Until now, 167 TEM β-lactamases have been
reported in a list compiled and maintained by Jacoby and
Bush [9] which is referred further in this paper as "TEM
mutation table". Each TEM β-lactamase is characterized
by its name and mutation profile which is the set of
amino acid substitutions at positions relative to the refer-
ence sequence TEM-1. A new TEM β-lactamase which is
qualified and assigned in the TEM mutation table must
have arisen naturally, is fully sequenced, and harbors a
new mutation profile. Amino acids in the TEM β-lacta-
mase sequence are numbered according the scheme pro-
posed by Ambler [10]. All TEM β-lactamases included in
the TEM mutation table differ from TEM-1 by up to seven
mutations. 6 pairs of TEM β-lactamases are identical
(TEM-1 and TEM-98, TEM-3 and TEM-14, TEM-10 and
TEM-23, TEM-30 and TEM-99, TEM-34 and TEM-97,
TEM-63 and TEM-64). For 11 TEM β-lactamases, the
amino acid sequences have not yet been released or were
withdrawn (TEM-41, 62, 69, 100, 119, 140, 148, 153,
154, 155, and 156), and therefore were excluded from our
analysis. The NCBI peptide database and the TEM muta-
tion table are developed in different ways. While the NCBI
peptide database is open for submission of new sequences
without external validation, the TEM mutation table is
curated by experts in the β-lactamase field. As a conse-
quence, the number of TEM-like sequences in the NCBI
peptide database is rapidly growing, but is has become
difficult to analyze this data, to detect inconsistencies, and
eventually to reconcile sequence and naming informa-
tion. Thus, 156 well-characterized TEM β-lactamases were
used as a starting point to set up a TEM β-lactamase data-
base and to identify inconsistencies in sequences from the
NCBI peptide database, to detect TEM β-lactamases with a
novel mutation profile, and to identify new amino acid
positions at which mutations can occur.
Construction and content
Construction
Development and construction of LacED
The LacED was set up using the generic data warehouse
system DWARF [11]. The underlying data model of
DWARF assists the systematic building of a family-specific
protein database from various data sources and supports
the analysis of relationships between protein sequence
and structure.
The amino acid sequence of the TEM-1 β-lactamase from
E. coli (GenInfo Identifier GI: 41056932) was used as seed
sequence. A BLAST search [12] was performed against the
NCBI protein database with an E-value threshold of 10-120
and without filtering of low-complexity regions. For each
individual BLAST result, the GIs of the hits were extracted
and the complete database entries were downloaded as
XML file from the NCBI peptide database. Subsequently,
information such as sequence, source organism, position-
specific annotation, and functional description was
extracted and parsed into the LacED by an automated
retrieval system. Amino acid sequences which differed by
at least one residue from the TEM-1 seed sequence were
stored in the LacED as a new protein entry. Sequences
which were 100% identical were assigned to the same pro-
tein entry.
Additionally, as a further data source the information of
the TEM mutation table – except for 11 withdrawn or
unreleased TEM β-lactamases – was incorporated into the
LacED. Using the TEM-1 sequence and the mutation pro-
files stored in the TEM mutation table, all TEM sequences
were generated and parsed into the LacED. For BLAST
results representing protein structures, monomers were
extracted from the PDB database [13] and deposited as
structure entries.
After an initial building of the database, all entries were
manually checked, and fusion proteins containing a TEM
β-lactamase were removed from the database. Protein
entries originating from BLAST results close to the E-value
threshold and with more than 15 substitutions withBMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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respect to TEM-1 were manually removed. This threshold
was chosen because it corresponds to two times the max-
imum number of substitutions of currently assigned TEM
β-lactamases.
The LacED is updated weekly. A script searches the NCBI
protein database and retrieves new entries as described
above.
Identification and naming of TEM β-lactamase sequences
For each protein entry in the LacED, a pairwise sequence
alignment with the TEM-1 β-lactamase sequence was per-
formed using ClustalW [14]. By comparing each residue
pair of the aligned sequences, changes with respect to the
TEM-1 sequence were detected, and the mutation profile
of the protein was identified. Subsequently, the mutation
profile was matched against those mutation profiles listed
in the TEM mutation table for the already assigned TEM β-
lactamase sequences.
In case of 100% identity in sequence and length to an
already assigned TEM β-lactamase, the sequence was
added to the respective protein entry and described by the
TEM number and the corresponding mutation profile.
Otherwise, a new protein entry was created and its muta-
tion profile was stored. For protein entries with a shorter
or longer sequence, the difference in length can either
arise from insertions or deletions inside the protein
sequence or at the N- and C-termini. Insertions and dele-
tions inside the protein sequence were annotated as:
'A249-' denotes the deletion of residue 249 with respect to
TEM-1, '-41.1R -41.2T' denotes the insertion of arginine as
first and threonine as second residue after position 41.
Missing N- or C-terminal residues were annotated as fol-
lows: 'N-11 C-12' denotes 11 and 12 residues missing at
the N- or C-termini, respectively. Protein entries with lack-
ing residues at the N- and C-terminus but which were
identical to an already existing full-length protein entry
were named 'fragment of TEM-X' with X the correspond-
ing number of the assigned TEMs
Multisequence alignment and feature annotation
Amino acids in the region of the signal sequence or at the
active site were annotated according to the available infor-
mation from source databases. The protein sequence orig-
inating from microorganisms will be referred to in this
paper by the name of the organism or by "uncultured soil
bacteria", while sequences from cloning vectors or other
synthetic constructs will be referred to as "artificial
source". Secondary structure information was calculated
using DSSP [15], stored, and used for annotation. The
multisequence alignment was used to enrich annotation
information and control the annotation quality. The indi-
vidual amino acids in the sequence and in the alignments
are numbered according to the scheme suggested by
Ambler [10]
Reconciliation of data inconsistencies
A systematic comparison of entries of the NCBI peptide
database and the TEM mutation table allows to reconcile
NCBI peptide database entries which are inconsistent in
their mutation profile or their name. The wrong name
assignment is corrected in the LacED if the mutation pro-
file is included in TEM mutation table. A sequence with a
new mutation profile is stored in the LacED as new TEM
β-lactamase, even if it has been named by the authors by
a (wrong) TEM name in the NCBI peptide database. A link
from the reconciled LacED entry to the original NCBI pep-
tide database entry allows the author of the respective
entry to correct an erroneous entry.
Content
Data content of the LacED
In total, 2399 entries resulting from the search against the
NCBI protein database were parsed into the LacED. Addi-
tionally, 156 sequences including the duplicated
sequences were parsed from the TEM mutation table into
the LacED, except for 11 withdrawn or unreleased TEM β-
lactamases. This analysis resulted in a total of 336 distinct
protein entries with a unique sequence. The assignment of
the 2399 parsed sequences to the 336 proteins is not
equally distributed: while 20% of all sequence entries are
unique, 80% of all entries correspond to only two TEM
proteins, TEM-1 and TEM-116. Of the 421 TEM-1
sequences, 164 sequences originate from microorganisms
while the others are from artificial sources. Of the 1380
TEM-116 sequences, only 14 sequences originate from
microorganism, while the majority of them are from arti-
ficial sources such as expression or cloning vectors and
other synthesis constructs. For E-values above 10-120, the
search against the NCBI protein database resulted in β-
lactamases of the PLA, OKB-P, and LEN type, which are
chromosomally encoded β-lactamases. At an E-value
threshold of 10-104, the first SHV β-lactamases appear in
the search results.
Information on TEM crystal structures was also included
in the LacED. 37 PDB structures were assigned to 22 dif-
ferent LacED entries based on sequence identity. All 37
structures lack the 23 amino acids of the signal sequence.
The majority of the 336 LacED protein entries were found
in the NCBI peptide database and were not described in
the TEM mutation table (180 sequences). 113 protein
sequences were found in both databases and 43 sequences
were characterized in the TEM mutation table but not
found in the NCBI (figure 1).
New mutation profiles in sequences of microbial origin
Half of the 180 TEM β-lactamases with a new mutation
profile which have been found in the NCBI peptide data-
base but not described yet in the TEM mutation table were
of microbial origin. Of them, 26 protein entries were fullBMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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length sequences found in defined organisms (table 1), 6
protein entries were shorter sequences lacking several res-
idues (table 2), and 57 protein entries were protein frag-
ments extracted from "uncultured soil bacteria"
(Additional file 1: Table S1).
As an example, protein entry GI 157676818 originates
from  E. coli and was directly submitted as nucleotide
sequence to the EMBL Nucleotide Sequence Database.
The translated sequence is of full length and has a substi-
tution of threonine at position 188 to lysine. A substitu-
tion at this position has not yet been documented in the
TEM mutation table. Protein entry GI 90110162 also orig-
inates from E. coli, lacks 2 C-terminal amino acids, and
has the mutation profile R204W, M211V. The occurrence
of substitutions at position 204 is known (e.g. R204Q in
TEM-70), but a substitution to tryptophan has not been
described yet. Position 211 is a novel location for a substi-
tution in the TEM β-lactamase sequence.
New mutation profiles in sequences from artificial sources
In total, 31 full length proteins with a new mutation pro-
file were identified from artificial sources such as cloning
or expression vectors. The amino acid substitutions occur
not only at the already described positions, but also at
novel positions different from those reported in the TEM
mutation table. Most novel mutation profiles include the
substitutions V84I and A184V, and therefore are probably
derived from TEM-116.
As an example, the protein from cloning vector pRSQ (GI
1003002) has a length of 286 residues and the mutation
profile V84I, L152F, A184V. The substitutions V84I and
A184V are found in TEM-116, but the substitution L152F
is new. A list of the 31 proteins from artificial sources,
together with their mutation profile and corresponding GI
is provided in Additional file 1: Table S2.
Data inconsistencies
A set of 55 protein entries was found to have inconsistent
annotation. Of these, 12 protein entries were inconsistent
in terms of TEM number assignment or in terms of the
reported mutation profile. They show differences between
their respective entries in the NCBI peptide database and
the TEM mutation table, or between the NCBI peptide
database entry and the respective publication (table 3). As
an example, the protein sequence with the GI 15081590
is described as TEM-102 with the mutation profile A25V,
H26R, A184V, L250V, but the TEM mutation table lists
TEM-102 with the completely different mutation profile
L21F, R164S, T265M. While the protein sequence with the
GI 15081590 was submitted to GenBank in 2002, the
TEM-102 entry in the TEM mutation table was docu-
mented in 2003 [16].
Fragments of assigned TEM β-lactamases
Another group of 39 protein entries consists of TEM β-
lactamase sequences with lacking residues but otherwise
known mutation profile. They were identified as frag-
ments corresponding to already assigned TEM β-lactama-
ses. As an example, the protein entries GI 28192514 and
145558692 are annotated as TEM-117 and TEM-131,
respectively. However, the sequences are missing 12 and
11 residues at the N-terminal and 19 and 12 residues at
the C-terminus, respectively. A list of all 39 protein entries
with missing residues is provided (Additional file 1: Table
S3).
Analysis of amino acid substitutions and substitution 
positions
Besides the known amino acid substitutions documented
in the TEM mutation table, 35 new substitutions in pro-
tein entries originating from microbial organisms have
been identified in full length sequences and in fragments.
New substitutions occurred either at already described
positions with an exchange into a new residue (10 substi-
tutions) or at completely new positions in the protein
sequence (Additional file 1: Table S4). The substitutions
are spread over the complete protein sequence, including
the signal peptide. Most of the substitutions are located at
the protein surface and are distant from the active site,
with the exception of Lys234 whose side chain is 3.4 Å dis-
tant to the Ser70 side chain and Met186 which is buried
in the protein core (figure 2).
Protein entries derived from artificial sources such as clon-
ing vectors contained 31 novel substitutions, including 5
substitutions at positions which were already described
for sequences originating from microbial sources (Addi-
The data sources of protein sequences in LacED Figure 1
The data sources of protein sequences in LacED.BMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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Table 1: Sequences with new mutation profiles from microbial source
GI Mutation Source organism
112785110 R65H Escherichia coli
112785108 T118A Escherichia coli
223006551 M155I Proteus mirabilis
154263799 A184V Escherichia sp. Sflu5
38456216 M186I Streptococcus pneumoniae
157676818 T188K Escherichia coli
12018137 E240G Escherichia coli
213133718 N276I Escherichia coli
112785106 A280D Escherichia coli
34099626 A284T Acinetobacter baumannii
190410144 F24L A25S Neisseria gonorrhoeae
67464385 S70G V84I A184V Escherichia coli
77021517 S53G V84I A184V Shigella flexneri
82395024 P226L R244L A248E Escherichia coli
110610033 Q39K R164S E240K Proteus mirabilis
55140586 L12A I13L P14S G92D Pseudomonas aeruginosa
33318322 Q39K E104K R164S K215R Klebsiella pneumoniae
112785120 V84I I173K A184V K234T Enterococcus gallinarum
57236771 I5F K55G H153R Vibrio cholerae
110835657 G283E A284K S285Q L286K I287C K288L H289T W290D Acetobacter pasteurianus
2970345 Q39K L51P E104K R164S A187R S223C F230L Providencia stuartii
15149330 S4D I5P H289L Escherichia coli
15149328 S4D I5P M69V H289L Escherichia coli
15149326 S4D I5P R244S H289L Escherichia coli
20805894 S4D I5P V80E G196S N276S Salmonella typhimurium
2648043 A42S R43T V44S P145S K146Q R178A E212- G238R Serratia marcescensBMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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Table 2: Protein fragments from microbial source containing new mutations
GI Number of 
residues missing
Source organism Description
90110162 C-2 Escherichia coli New mutation profile, the mutation at M211 is not in TEM mutation table
26245317 C-3 Erwinia amylovora P145X T181X A184V I263X T265P, there are three undefined residues 
in the sequence. The mutation T265P is not in the TEM mutation table
166078558 C-14 Escherichia coli N276K is not in TEM mutation table
166078576 C-13 Escherichia coli The new mutation N274D is not in the TEM mutation table
117950175 N-1 C-8 Salmonella typhimurium The new mutation I282E is not in the TEM mutation table
45758090 C-17 Salmonella enterica New mutation profile T266D S268E Q269S A270G T271N. The mutation 
at position 266, 269, 270, 271 are not in TEM mutation table, at the 
end of the sequence.
Table 3: Inconsistencies of mutation profiles reported in different data sources
Name and mutation profile reported by Inconsistency
NCBI peptide database TEM mutation table*
RTEM-1: F66S A184V (GI:2623824) RTEM-1 = TEM-1
no mutation
Same name, different mutation profile
TEM-1: F24L A25S (GI:89112911) TEM-1: no mutation Same name, different mutation profile
(GI: 213133718) TEM-1: no mutation Same name, different mutation profile
TEM-26B beta-lactamase: R164S (GI:149169) TEM-12: R164S Different name, same mutation profile
IRT-18: M69L R244S (GI:6688989) TEM-77: M69L R244S IRT-18 is TEM-73*.
Different name, same mutation profile
TEM-102: A25V H26R A184V L250V 
(GI:15081590)
TEM-102: L21F R164S T265M Same name, different mutation profile
TEM-128: A284T (GI:38456216) TEM-128: D157E Same name, different mutation profile
M186I (GI:38456216) Q39K E104K R164S Same name, different mutation profile
TEM-136: L12A I13L P14S G92D (GI:55140586) TEM-136: R164S A237T E240K S268G Same name, different mutation profile
TEM-144: P226L R244L A248E (GI:82395024) TEM-144: R164C E240K Same name, different mutation profile
(GI:161367442) TEM-162: E28K D38N E64K V84I N100S L102V 
A184V
Same name, different mutation profile
TEM-166: S59G R164S A237T E240K 
(GI:183584860)
TEM-166: R120G Same name, different mutation profile
http://www.lahey.org/Studies/temtable.aspBMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
Page 7 of 9
(page number not for citation purposes)
tional file 1: Table S5). The localization of the substitu-
tions in the protein structure is similar to those found in
sequences from microbial origin (figure 3).
Comparing the novel substitutions found in sequences
originating from microbial organisms with those originat-
ing from artificial sources, only 12 positions are in com-
mon (position 25, 43, 80, 84, 104, 164, 178, 184, 187,
212, 240, and 284). However, in most cases the substi-
tuted amino acids were different depending on the source
of the sequence.
Additionally, 64 novel substitutions have been found in
uncultured soil bacteria. Details on these substitutions are
provided as additional file (Additional file 1: Table S6).
Utility
A multisequence alignment of all 336 protein entries was
generated using CLUSTALW. For protein structures, all
sequence entries were included and displayed with
aligned secondary structure information. Proteins were
labeled by the GIs and are linked to the NCBI protein
database. Annotation of individual residues is visualized
by color-coding in the alignment and by moving the
mouse cursor over the respective colored residues. Protein
tables provide information on the protein name, muta-
tion, number of residues missing at the N- and C-terminal
(in case of fragments) as well as on the source organism.
The accession codes corresponding to each LacED protein
entry are also shown and linked to the source database. As
an alternative to the multisequence alignment, the TEM
variants are visualized as mutations relative to the
sequence of TEM-1. Substitution positions are colored
and annotated by the name of the respective variant
(TEM-2, TEM-3...). BLAST search against the LacED can be
done using the BLAST function.
Discussion
Differences between data sources
336 TEM β-lactamase protein sequences were retrieved
from two data sources, the NCBI peptide database [17]
and the TEM mutation table [9]. Only 113 of the 156 TEM
β-lactamases of the TEM mutation table could be found in
the NCBI peptide database. The references given in the
TEM mutation table for the remaining 43 TEM β-lacta-
mase sequences were either labeled as "personal commu-
nication" (TEM-18, 19, 61, and 163, 165), or the
respective publication did not contain a database acces-
sion number.
On the other hand, the search in the NCBI peptide data-
base resulted in 180 new TEM β-lactamase sequences as
compared to the TEM mutation table, including 89
sequences from microbial origin and 91 synthetic con-
structs.
Detection of novel TEM β-lactamase variants and amino 
acid substitution
Most of the novel mutation profiles originate from artifi-
cial constructs such as cloning vectors, and hence do not
qualify for the assignment of a new TEM number. If it is
assumed that the TEM β-lactamase encoded by such a con-
struct is functional, the analysis of novel mutation profiles
The structure of TEM-1 β-lactamases (PDB entry 1BTL) with  the positions of substitutions found in sequences from micro- bial origin Figure 2
The structure of TEM-1 β-lactamases (PDB entry 
1BTL) with the positions of substitutions found in 
sequences from microbial origin. Amino acid side chains 
are shown in stick representation: substitutions occurring at 
already described positions (green), substitutions at novel 
positions (red), and active site residues (yellow). Residues at 
positions 53, 238, 248, 283 can not be seen from this view.
The structure of TEM-1 β-lactamases (PDB entry 1BTL) with  the positions of substitutions found in sequences from artifi- cial sources Figure 3
The structure of TEM-1 β-lactamases (PDB entry 
1BTL) with the positions of substitutions found in 
sequences from artificial sources. (PDB: 1BTL). Amino 
acid side chains are shown in stick representation: substitu-
tions occurring at already described positions (green), substi-
tutions at novel positions (red), and active site residues 
(yellow).BMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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is valuable data, though, to study sequence-function rela-
tionships and to predict mutations which might also
occur in microbial TEM β-lactamases in the future.
However, 26 full length TEM β-lactamase sequences with
a novel mutation profile were detected, which originate
from microbial organisms and thus satisfy the require-
ments of Jacoby and Bush for assignment to a new TEM
number. It should be noted that the occurrence of these
novel sequences in public databases does not necessarily
mean that the corresponding proteins are expressed. It
might well be the case that sequencing errors or errors
upon data transfer are the reason for the novel mutation
profile.
In addition to the full length sequences, 6 fragments from
microbial source with a new mutation profile were found.
Because there might be more substitutions present in the
lacking part of the sequence, the current information on
these fragments is not sufficient to assign a new TEM
number. However, the new mutation sites or combina-
tions of mutations contribute to the study of sequence-
function relationships.
The 57 TEM β-lactamase sequences originating from
uncultured soil bacteria constitute the largest number of
sequences with a novel mutation profile. Because "uncul-
tured soil bacterium" has to be considered as a natural
source, these proteins would qualify for the assignment of
new TEM numbers, but certainly further study of these
sequences is necessary.
The systematic analysis of all sequences identified 35
novel amino acid substitutions in sequences from micro-
bial origin, which are not yet described in the TEM muta-
tion table. Among these mutations, P226 and K234
provide an insight into the evolution of new specificities.
From a previous in vitro experiment with the antibiotic
ampicillin, it was concluded that amino acid substitutions
in these positions are not tolerated [18]. However, the
authors suggested that mutations at these sites might be
required for hydrolysis of other β-lactam antibiotics,
which has been demonstrated by site-directed mutagene-
sis for position 234 [19]. The occurrence of β-lactamases
from Enterococcus gallinarum harboring the substitution
K234T (GI 112785120) and from E. coli harboring the
substitution P226L (GI 82395024) demonstrates that in
vitro  studies can predict events in natural evolution of
TEM β-lactamases, and that a challenge by different anti-
biotics will lead to different responses. Thus it confirms
the high plasticity of β-lactamase sequences in response to
evolutive pressure by a broad spectrum of antibiotics.
Data inconsistencies and reconciliation
The 12 NCBI peptide database entries with inconsisten-
cies include wrongly named sequences (IRT-18 and TEM-
77, GI 6688989) and sequences for which the mutation
profiles do not correspond to those listed in the TEM
mutation table.
The protein sequence GI 38456216 was submitted as
'Streptococcus pneumoniae plasmid beta-lactamase TEM-
129' to the NCBI peptide database [20]. The translated
protein sequence has the mutation profile M186I, which
differs from the mutation profile reported for TEM-129 in
the TEM mutation table (Q39K, E104K, and R164S). So
far, this is the only case reporting that Streptococcus pneu-
moniae contains a known β-lactamases. The mistake was
then identified with the presence of β-lactamase DNA in
some brands of commercial Taq polymerase [21], but the
entry is still available in the NCBI peptide database.
An interesting case is the occurrence of 5 sequences with
the substitutions S4D, I5P in the leader peptide. All of
them have been reported to originate from Irish bacteria
strains (GI 15149330, 15149328, 15149342, 42525360,
and 13676302). Three of them were directly submitted by
the same authors into the public database, two sequences
were submitted along with a publication [16], describing
one of the sequences as TEM-102 with the mutation pro-
file L21F, R164S, T265M. However, the substitutions S4D
and I5P that we found in all five sequences were not men-
tioned in the publication, nor listed in the TEM mutation
table.
The inconsistencies were reconciled in the LacED based
on the information from the TEM mutation table. Most of
the inconsistencies are either sequences with the same
TEM number but a different mutation profile in the NCBI
peptide database and the TEM mutation table or
sequences with the same mutation profile but a different
TEM number in the NCBI peptide database and the TEM
mutation table. In the first case, the sequence was consid-
ered as a new TEM-like sequence, in the second case the
information of this entry was corrected according to the
TEM mutation table and stored in the LacED. A link from
each LacED entry to the original entry in the NCBI peptide
database allows the authors of the submitted sequence to
trace the inconsistency and to correct the data.
Open questions
The observed inconsistencies in NCBI peptide database
entries between the annotated TEM name and the muta-
tion profile demonstrate the need for a careful analysis of
new sequence entries by a systematic comparison to
already existing sequences. Although major scientific jour-
nals require authors who submit a new TEM β-lactamase
sequence to have the agreement of the curator of TEM
mutation table prior to publication, the NCBI peptide
database allows the submission of new sequences without
further validation. A major problem of the observed
inconsistencies lies in the fact that researchers who are notBMC Genomics 2009, 10:390 http://www.biomedcentral.com/1471-2164/10/390
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TEM β-lactamase experts might rely on the information
found in the NCBI peptide database. We therefore con-
sider the LacED as a valuable tool to detect such inconsist-
encies and report them to the interested community.
Therefore, a tool such as the LacED provides a valuable
approach to systematically analyze new entries and to
compare them to existing sequence and annotation infor-
mation.
Conclusion
The amount of sequence and structure data of TEM β-
lactamases available in public databases is increasing rap-
idly. The Lactamase Engineering Database enables a sys-
tematic analysis of sequence and annotation information
from different data sources. It helps to identify inconsist-
encies and to discover novel mutation profiles. In the
future, the Lactamase Engineering Database will be
extended to the other lactamase families and classes.
Availability and requirements
The LacED is accessible at http://www.LacED.uni-stutt
gart.de by a JavaScript-enabled WWW browser.
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